EUVIMEDEUVIMED entdecken
Open Access

Digital Phenotyping and Noninvasive Quality-of-Life Monitoring in Glioblastoma: Feasibility and Usability Study of the Lalaby-Glio App

Sabina Asensio-Cuesta iD, Elies Fuster-García iD, Juan M García-Gómez iD, Carlos Sáez iD, Daniel Sánchez-García iD, Ángel Sánchez-García iD, Jorge Soler iD, Inmaculada Maestu iD, Teresa Soria-Comes iD, Maria De Julian Campayo iD

JMIR Formative Research · 2026

DOI: 10.2196/89765 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JMIR Formative Research, 2026. Verfasst von Sabina Asensio-Cuesta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Universitat Politècnica de València, Instituto de Tecnologías de la Información y Comunicaciones, Valencia, Spain. Hauptthemen laut MEDLINE: Glioblastoma, Quality of Life, Mobile Applications, Brain Neoplasms. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor in adults, with a poor prognosis despite Stupp protocol treatment. Given the substantial burden of the disease and its therapies, monitoring health-related quality of life (HRQoL) is essential. Smartphone-based approaches may enable continuous, low-burden monitoring.

Objective

This study aims to evaluate the feasibility and usability of the Lalaby-Glio app for monitoring HRQoL in patients with GBM and to explore preliminary hypothesis-generating associations between subjective global quality of life (QoL) and passive smartphone sensor data.

Methods

The study comprised four phases: (1) adaptation of Lalaby for GBM-specific monitoring by combining passive smartphone sensors (movement, step count, location, sound, light exposure, internet use, and call activity) with a clinician-designed daily 5-item questionnaire and weekly European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (QLQ-C30) and Quality of Life Questionnaire-Brain Neoplasm 20 (QLQ-BN20); (2) a 6-week feasibility study in 4 adults (aged ≥18 years) initiating Stupp treatment; (3) usability testing in patients with GBM and a complementary nonpatient sample of 103 healthy adults using either screenshot mock-ups or the installed app; and (4) exploratory Spearman correlation analyses of associations between passive sensor data and subjective global QoL using patient-level bootstrap, with no causal or predictive claims inferred due to the small sample size.

Results

We enrolled 4 patients (3 men, 1 woman; mean age 54.3, SD 8 years), of whom 3 completed all 6 weeks, and 1 died after 2 weeks. Engagement was high, with 168 questionnaires completed (22 QLQ-C30, 19 QLQ-BN20, and 127 daily status entries). Mean app use was 1.8 (SD 2.7) minutes per day, and mean completion time for the weekly questionnaires was 7.2 (SD 3.3) minutes. Weekly patient-reported outcome measures (PROMs) revealed substantial interindividual and intraindividual variability in functioning, symptoms, and global QoL during treatment. Usability among patients with GBM was favorable (overall mean 3.7/5). Among healthy participants (mean age 20.9, SD 1.4 years; 72/103, 69.9% women), those who installed the app (n=46) achieved a mean System Usability Scale score of 72.9 (SD 10.2), above the standard benchmark, and 91.3% (94/103) judged the nature-inspired design appropriate for oncology. Passive sensing yielded 91.7 MB of data; global QoL correlated negatively with calls (ρ=−0.598; P=.01) and movement (ρ=−0.604; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaQuality of LifeMobile ApplicationsBrain NeoplasmsHumansFemaleMiddle AgedFeasibility StudiesMaleAdultAgedSurveys and QuestionnairesPhenotypeDigital Health

Stichwörter der Autor:innen

PROMsQoLdigital phenotypingfeasibilityglioblastomamobile healthpassive sensingpatient-reported outcome measuresquality of lifeusability

Autor:innen und Institutionen

  • Universitat Politècnica de València, Instituto de Tecnologías de la Información y Comunicaciones, Valencia, Spain.
  • Consorcio Hospitalario Provincial de Castellón, Castellón, Spain.
  • Hospital Universitario Doctor Peset, Valencia, Spain.

ORCID-Profile: Sabina Asensio-Cuesta, Elies Fuster-García, Juan M García-Gómez, Carlos Sáez, Daniel Sánchez-García, Ángel Sánchez-García, Jorge Soler, Inmaculada Maestu, Teresa Soria-Comes, Maria De Julian Campayo

Zitieren

APA

Asensio-Cuesta, S., Fuster-García, E., García-Gómez, J. M., Sáez, C., Sánchez-García, D., Sánchez-García, Á., Soler, J., Maestu, I., Soria-Comes, T., & De Julian Campayo, M. (2026). Digital Phenotyping and Noninvasive Quality-of-Life Monitoring in Glioblastoma: Feasibility and Usability Study of the Lalaby-Glio App. JMIR Formative Research. https://doi.org/10.2196/89765

Vancouver

Asensio-Cuesta S, Fuster-García E, García-Gómez JM, Sáez C, Sánchez-García D, Sánchez-García Á, et al. Digital Phenotyping and Noninvasive Quality-of-Life Monitoring in Glioblastoma: Feasibility and Usability Study of the Lalaby-Glio App. JMIR Formative Research. 2026. doi:10.2196/89765

BibTeX
@article{AsensioCuesta2026,
  author = {Asensio-Cuesta, Sabina and Fuster-García, Elies and García-Gómez, Juan M and Sáez, Carlos and Sánchez-García, Daniel and Sánchez-García, Ángel and Soler, Jorge and Maestu, Inmaculada and Soria-Comes, Teresa and De Julian Campayo, Maria},
  title = {Digital Phenotyping and Noninvasive Quality-of-Life Monitoring in Glioblastoma: Feasibility and Usability Study of the Lalaby-Glio App},
  journal = {JMIR Formative Research},
  year = {2026},
  doi = {10.2196/89765}
}
Kostenlos starten →